Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

22.31 -0.18 (-0.80%)
Streaming Delayed Price Updated: 11:01 AM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Schrödinger to Present at Jefferies Global Biopharma Conference
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
3 Key Biotech Trends for 2023 And Beyond
New opportunities are becoming apparent, but so are fresh risks in the biotech field. 
Via The Motley Fool
3 High-Reward Stocks Riding the AI Boom
AI will make many companies' businesses much more effective and profitable, so the best AI stocks are very attractive. 
Via InvestorPlace
4 Analysts Have This to Say About Schrodinger
 
Via Benzinga
Schrodinger: Q1 Earnings Insights
 
Via Benzinga
Earnings Outlook For Schrodinger
 
Via Benzinga
Analyst Expectations for Schrodinger's Future
 
Via Benzinga
Why Shares of Schrödinger Were Up Today
The company delivered a nice earnings surprise. 
Via The Motley Fool
7 Growth Stocks That Could Double Your Money in 2023
For investors that really want to roll the dice, these are the enticing growth stocks that could double your money. 
Via InvestorPlace
Why Investors Should Keep an Eye on These 3 AI Start-Ups, Including UiPath and C3.ai
The future is here, and you can be a cutting-edge investor by plowing money into one or more of these stocks. 
Via The Motley Fool
The 7 Most Undervalued Growth Stocks for Your May Buy List
Economic data and a short-covering rally suggest that the outlook for undervalued growth stocks is improving. 
Via InvestorPlace
Schrödinger Reports Strong First Quarter 2023 Financial Results
From Schrödinger, Inc.
Via Business Wire
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
Via Talk Markets
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Schrödinger Publishes Inaugural Corporate Sustainability Report
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Announce First Quarter 2023 Financial Results on May 4
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
The C3.ai Stock Debate: Overpriced or Underestimated?
The valuation of AI stock was attractive many months ago, but at this point their price-sales ratio has become quite elevated. 
Via InvestorPlace
3 Industries Set to Be Transformed by the AI Revolution
AI will allow companies in many sectors to save a great deal of money and tremendously increase their revenue. 
Via InvestorPlace
The 3 Best AI Stocks to Buy Right Now
Here are the best AI stocks to buy now as companies look to harness the power of this disruptive technology. 
Via InvestorPlace
3 Tech Stocks to Buy for the Fourth Industrial Revolution
These companies all utilize multiple technologies that are part of the Fourth Industrial Revolution, making them great tech stocks to buy. 
Via InvestorPlace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Evogene Offers An Excellent Risk/Reward Ratio
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
Via Talk Markets
Not Quite a Bailout: So Much Banking News to Discuss
Plus, two Motley Fool analysts share their insight on a pair of stocks to watch. 
Via The Motley Fool
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
MarketBeat Week in Review – 3/6 - 3/10
Stocks are down sharply to end the week, and the MarketBeat staff continues to show investors why dividend stocks need to be part of your playbook 
Via MarketBeat
Topics Artificial Intelligence Economy
3 Amazing AI Stocks for Your March Buy List
With the Street catching onto the transformational power of AI, these amazing AI stocks are very well-positioned to climb tremendously. 
Via InvestorPlace
Schrodinger is an AI-Powered Drug Discovery Developer to Watch
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117 
Via MarketBeat
Topics Artificial Intelligence
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.